<VariationArchive VariationID="803271" VariationName="NM_024306.5(FA2H):c.340_363+8del" VariationType="Deletion" Accession="VCV000803271" Version="3" RecordType="classified" NumberOfSubmissions="2" NumberOfSubmitters="2" DateLastUpdated="2024-02-14" DateCreated="2020-01-11" MostRecentSubmission="2024-02-14">
  <RecordStatus>current</RecordStatus>
  <Species>Homo sapiens</Species>
  <ClassifiedRecord>
    <SimpleAllele AlleleID="791640" VariationID="803271">
      <GeneList>
        <Gene Symbol="FA2H" FullName="fatty acid 2-hydroxylase" GeneID="79152" HGNC_ID="HGNC:21197" Source="submitted" RelationshipType="within single gene">
          <Location>
            <CytogeneticLocation>16q23.1</CytogeneticLocation>
            <SequenceLocation Assembly="GRCh38" AssemblyAccessionVersion="GCF_000001405.38" AssemblyStatus="current" Chr="16" Accession="NC_000016.10" start="74712969" stop="74774820" display_start="74712969" display_stop="74774820" Strand="-" />
            <SequenceLocation Assembly="GRCh37" AssemblyAccessionVersion="GCF_000001405.25" AssemblyStatus="previous" Chr="16" Accession="NC_000016.9" start="74746852" stop="74808728" display_start="74746852" display_stop="74808728" Strand="-" />
          </Location>
          <OMIM>611026</OMIM>
        </Gene>
      </GeneList>
      <Name>NM_024306.5(FA2H):c.340_363+8del</Name>
      <CanonicalSPDI>NC_000016.10:74740014:CCAGGTACCTTGTCCCAATCCACCACTTTGAACC:CC</CanonicalSPDI>
      <VariantType>Deletion</VariantType>
      <Location>
        <CytogeneticLocation>16q23.1</CytogeneticLocation>
        <SequenceLocation Assembly="GRCh38" AssemblyAccessionVersion="GCF_000001405.38" forDisplay="true" AssemblyStatus="current" Chr="16" Accession="NC_000016.10" start="74740015" stop="74740046" display_start="74740015" display_stop="74740046" variantLength="32" positionVCF="74740014" referenceAlleleVCF="GCCAGGTACCTTGTCCCAATCCACCACTTTGAA" alternateAlleleVCF="G" />
        <SequenceLocation Assembly="GRCh37" AssemblyAccessionVersion="GCF_000001405.25" AssemblyStatus="previous" Chr="16" Accession="NC_000016.9" start="74773913" stop="74773944" display_start="74773913" display_stop="74773944" variantLength="32" positionVCF="74773912" referenceAlleleVCF="GCCAGGTACCTTGTCCCAATCCACCACTTTGAA" alternateAlleleVCF="G" />
      </Location>
      <HGVSlist>
        <HGVS Assembly="GRCh38" Type="genomic, top-level">
          <NucleotideExpression sequenceAccessionVersion="NC_000016.10" sequenceAccession="NC_000016" sequenceVersion="10" change="g.74740017_74740048del" Assembly="GRCh38">
            <Expression>NC_000016.10:g.74740017_74740048del</Expression>
          </NucleotideExpression>
        </HGVS>
        <HGVS Assembly="GRCh37" Type="genomic, top-level">
          <NucleotideExpression sequenceAccessionVersion="NC_000016.9" sequenceAccession="NC_000016" sequenceVersion="9" change="g.74773915_74773946del" Assembly="GRCh37">
            <Expression>NC_000016.9:g.74773915_74773946del</Expression>
          </NucleotideExpression>
        </HGVS>
        <HGVS Type="genomic">
          <NucleotideExpression sequenceAccessionVersion="NG_017070.1" sequenceAccession="NG_017070" sequenceVersion="1" change="g.39786_39817del">
            <Expression>NG_017070.1:g.39786_39817del</Expression>
          </NucleotideExpression>
        </HGVS>
        <HGVS Type="coding">
          <NucleotideExpression sequenceAccessionVersion="NM_024306.5" sequenceAccession="NM_024306" sequenceVersion="5" change="c.340_363+8del" MANESelect="true">
            <Expression>NM_024306.5:c.340_363+8del</Expression>
          </NucleotideExpression>
          <MolecularConsequence ID="SO:0001575" Type="splice donor variant" DB="SO" />
        </HGVS>
      </HGVSlist>
      <XRefList>
        <XRef Type="rs" ID="1597556143" DB="dbSNP" />
      </XRefList>
    </SimpleAllele>
    <RCVList>
      <RCVAccession Title="NM_024306.5(FA2H):c.340_363+8del AND Hereditary spastic paraplegia 35" Accession="RCV000989633" Version="1">
        <ClassifiedConditionList TraitSetID="6693">
          <ClassifiedCondition DB="MedGen" ID="C3496228">Hereditary spastic paraplegia 35</ClassifiedCondition>
        </ClassifiedConditionList>
        <RCVClassifications>
          <GermlineClassification>
            <ReviewStatus>criteria provided, single submitter</ReviewStatus>
            <Description DateLastEvaluated="2019-05-28" SubmissionCount="1">Pathogenic</Description>
          </GermlineClassification>
        </RCVClassifications>
      </RCVAccession>
      <RCVAccession Title="NM_024306.5(FA2H):c.340_363+8del AND Spastic paraplegia" Accession="RCV002549731" Version="2">
        <ClassifiedConditionList TraitSetID="20865">
          <ClassifiedCondition DB="MedGen" ID="C0037772">Spastic paraplegia</ClassifiedCondition>
        </ClassifiedConditionList>
        <RCVClassifications>
          <GermlineClassification>
            <ReviewStatus>criteria provided, single submitter</ReviewStatus>
            <Description DateLastEvaluated="2022-07-17" SubmissionCount="1">Likely pathogenic</Description>
          </GermlineClassification>
        </RCVClassifications>
      </RCVAccession>
    </RCVList>
    <Classifications>
      <GermlineClassification DateLastEvaluated="2022-07-17" NumberOfSubmissions="2" NumberOfSubmitters="2" DateCreated="2020-01-11" MostRecentSubmission="2024-02-14">
        <ReviewStatus>criteria provided, multiple submitters, no conflicts</ReviewStatus>
        <Description>Pathogenic/Likely pathogenic</Description>
        <Citation Type="general">
          <ID Source="PubMed">25732363</ID>
        </Citation>
        <Citation Type="general">
          <ID Source="PubMed">26344562</ID>
        </Citation>
        <Citation Type="general">
          <ID Source="PubMed">25496456</ID>
        </Citation>
        <Citation Type="general">
          <ID Source="PubMed">16199547</ID>
        </Citation>
        <Citation Type="general">
          <ID Source="PubMed">20853438</ID>
        </Citation>
        <DescriptionHistory Dated="2023-02-02">
          <Description>Pathogenic</Description>
        </DescriptionHistory>
        <ConditionList>
          <TraitSet ID="20865" Type="Disease" ContributesToAggregateClassification="true">
            <Trait ID="32966" Type="Disease">
              <Name>
                <ElementValue Type="Preferred">Spastic paraplegia</ElementValue>
                <XRef ID="10DG0885" DB="Department Of Translational Genomics (developmental Genetics Section), King Faisal Specialist Hospital &amp; Research Centre" />
                <XRef ID="HP:0001258" DB="Human Phenotype Ontology" />
              </Name>
              <XRef ID="C0037772" DB="MedGen" />
              <XRef Type="primary" ID="HP:0001258" DB="Human Phenotype Ontology" />
              <XRef Type="secondary" ID="HP:0007062" DB="Human Phenotype Ontology" />
              <XRef Type="secondary" ID="HP:0007124" DB="Human Phenotype Ontology" />
              <XRef Type="secondary" ID="HP:0007216" DB="Human Phenotype Ontology" />
            </Trait>
          </TraitSet>
          <TraitSet ID="6693" Type="Disease" ContributesToAggregateClassification="true">
            <Trait ID="4413" Type="Disease">
              <Name>
                <ElementValue Type="Alternate">SPASTIC PARAPLEGIA 35, AUTOSOMAL RECESSIVE, WITH OR WITHOUT NEURODEGENERATION</ElementValue>
                <XRef Type="MIM" ID="612319" DB="OMIM" />
                <XRef Type="Allelic variant" ID="611026.0006" DB="OMIM" />
              </Name>
              <Name>
                <ElementValue Type="Alternate">Spastic paraplegia 35</ElementValue>
                <XRef ID="Leukodystrophy%2C+dysmyelinating%2C+and+spastic+paraparesis+with+or+without+dystonia/4201" DB="Genetic Alliance" />
              </Name>
              <Name>
                <ElementValue Type="Alternate">Leukodystrophy, dysmyelinating, and spastic paraparesis with or without dystonia</ElementValue>
              </Name>
              <Name>
                <ElementValue Type="Preferred">Hereditary spastic paraplegia 35</ElementValue>
                <XRef ID="MONDO:0012866" DB="MONDO" />
              </Name>
              <Name>
                <ElementValue Type="Alternate">Spastic paraplegia 35, autosomal recessive</ElementValue>
              </Name>
              <Symbol>
                <ElementValue Type="Alternate">SPG35</ElementValue>
                <XRef Type="MIM" ID="612319" DB="OMIM" />
              </Symbol>
              <AttributeSet>
                <Attribute Type="public definition">Fatty acid hydroxylase-associated neurodegeneration (FAHN) is characterized early in the disease course by central nervous system involvement including corticospinal tract involvement (spasticity), mixed movement disorder (ataxia/dystonia), and eye findings (optic atrophy, oculomotor abnormalities), and later in the disease course by progressive intellectual impairment and seizures. With disease progression, dystonia and spasticity compromise the ability to ambulate, leading to wheelchair dependence. Life expectancy is variable. FAHN is considered to be a subtype of neurodegeneration with brain iron accumulation (NBIA).</Attribute>
                <XRef ID="NBK56080" DB="GeneReviews" />
              </AttributeSet>
              <AttributeSet>
                <Attribute Type="GARD id" integerValue="10538" />
                <XRef ID="10538" DB="Office of Rare Diseases" />
              </AttributeSet>
              <Citation Type="review" Abbrev="GeneReviews">
                <ID Source="PubMed">21735565</ID>
                <ID Source="BookShelf">NBK56080</ID>
              </Citation>
              <Citation Type="review" Abbrev="GeneReviews">
                <ID Source="PubMed">23447832</ID>
                <ID Source="BookShelf">NBK121988</ID>
              </Citation>
              <XRef ID="171629" DB="Orphanet" />
              <XRef ID="C3496228" DB="MedGen" />
              <XRef ID="MONDO:0012866" DB="MONDO" />
              <XRef Type="MIM" ID="612319" DB="OMIM" />
            </Trait>
          </TraitSet>
        </ConditionList>
      </GermlineClassification>
    </Classifications>
    <ClinicalAssertionList>
      <ClinicalAssertion ID="2245965" SubmissionDate="2019-10-22" DateLastUpdated="2020-01-11" DateCreated="2020-01-11">
        <ClinVarSubmissionID localKey="NC_000016.9:g.74773913_74773944delCCAGGTACCTTGTCCCAATCCACCACTTTGAA|OMIM:612319" submittedAssembly="GRCh37" />
        <ClinVarAccession Accession="SCV001140162" DateUpdated="2020-01-11" DateCreated="2020-01-11" Type="SCV" Version="1" SubmitterName="Mendelics" OrgID="500035" OrganizationCategory="laboratory" />
        <RecordStatus>current</RecordStatus>
        <Classification DateLastEvaluated="2019-05-28">
          <ReviewStatus>criteria provided, single submitter</ReviewStatus>
          <GermlineClassification>Pathogenic</GermlineClassification>
        </Classification>
        <Assertion>variation to disease</Assertion>
        <AttributeSet>
          <Attribute Type="AssertionMethod">Mendelics Assertion Criteria 2017</Attribute>
          <Citation>
            <URL>https://submit.ncbi.nlm.nih.gov/ft/byid/chhjzatu/mendelics_assertion_criteria_2017.pdf</URL>
          </Citation>
        </AttributeSet>
        <ObservedInList>
          <ObservedIn>
            <Sample>
              <Origin>unknown</Origin>
              <Species TaxonomyId="9606">human</Species>
              <AffectedStatus>unknown</AffectedStatus>
            </Sample>
            <Method>
              <MethodType>clinical testing</MethodType>
            </Method>
            <ObservedData>
              <Attribute Type="Description">not provided</Attribute>
            </ObservedData>
          </ObservedIn>
        </ObservedInList>
        <SimpleAllele>
          <GeneList>
            <Gene Symbol="FA2H" />
          </GeneList>
          <VariantType>Variation</VariantType>
          <AttributeSet>
            <Attribute Type="HGVS">NC_000016.9:g.74773913_74773944delCCAGGTACCTTGTCCCAATCCACCACTTTGAA</Attribute>
          </AttributeSet>
        </SimpleAllele>
        <TraitSet Type="Disease">
          <Trait Type="Disease">
            <XRef DB="OMIM" ID="612319" Type="MIM" />
          </Trait>
        </TraitSet>
        <SubmissionNameList>
          <SubmissionName>MENDELICS_CLINVAR_020</SubmissionName>
        </SubmissionNameList>
      </ClinicalAssertion>
      <ClinicalAssertion ID="6157516" SubmissionDate="2024-02-08" DateLastUpdated="2024-02-14" DateCreated="2023-02-07">
        <ClinVarSubmissionID localKey="4050595|MedGen:C0037772" submittedAssembly="GRCh37" />
        <ClinVarAccession Accession="SCV003469398" DateUpdated="2024-02-14" DateCreated="2023-02-07" Type="SCV" Version="2" SubmitterName="Invitae" OrgID="500031" OrganizationCategory="laboratory" OrgAbbreviation="Invitae" />
        <RecordStatus>current</RecordStatus>
        <Classification DateLastEvaluated="2022-07-17">
          <ReviewStatus>criteria provided, single submitter</ReviewStatus>
          <GermlineClassification>Likely pathogenic</GermlineClassification>
          <Citation>
            <ID Source="PubMed">25496456</ID>
          </Citation>
          <Citation>
            <ID Source="PubMed">25732363</ID>
          </Citation>
          <Citation>
            <ID Source="PubMed">26344562</ID>
          </Citation>
          <Citation>
            <ID Source="PubMed">16199547</ID>
          </Citation>
          <Citation>
            <ID Source="PubMed">20853438</ID>
          </Citation>
          <Citation>
            <ID Source="PubMed">25496456</ID>
          </Citation>
          <Citation>
            <ID Source="PubMed">25732363</ID>
          </Citation>
          <Citation>
            <ID Source="PubMed">26344562</ID>
          </Citation>
          <Comment>ClinVar contains an entry for this variant (Variation ID: 803271). This variant is also known as [c.340_363del24][c.363+1_8del8]. While this particular variant has not been reported in the literature, loss-of-function variants in FA2H are known to be pathogenic (PMID: 25496456, 25732363, 26344562). This variant is not present in population databases (gnomAD no frequency). This variant results in the deletion of part of exon 2 (c.340_363+8del) of the FA2H gene. It is expected to disrupt RNA splicing. Variants that disrupt the donor or acceptor splice site typically lead to a loss of protein function (PMID: 16199547), and loss-of-function variants in FA2H are known to be pathogenic (PMID: 20853438, 25496456, 25732363, 26344562). Algorithms developed to predict the effect of sequence changes on RNA splicing suggest that this variant may disrupt the consensus splice site. In summary, the currently available evidence indicates that the variant is pathogenic, but additional data are needed to prove that conclusively. Therefore, this variant has been classified as Likely Pathogenic.</Comment>
        </Classification>
        <Assertion>variation to disease</Assertion>
        <AttributeSet>
          <Attribute Type="AssertionMethod">Invitae Variant Classification Sherloc (09022015)</Attribute>
          <Citation>
            <ID Source="PubMed">28492532</ID>
          </Citation>
        </AttributeSet>
        <ObservedInList>
          <ObservedIn>
            <Sample>
              <Origin>germline</Origin>
              <Species TaxonomyId="9606">human</Species>
              <AffectedStatus>unknown</AffectedStatus>
            </Sample>
            <Method>
              <MethodType>clinical testing</MethodType>
            </Method>
            <ObservedData>
              <Attribute Type="Description">not provided</Attribute>
            </ObservedData>
          </ObservedIn>
        </ObservedInList>
        <SimpleAllele>
          <GeneList>
            <Gene Symbol="FA2H" />
          </GeneList>
          <VariantType>Variation</VariantType>
          <AttributeSet>
            <Attribute Type="HGVS">NC_000016.9:g.74773913_74773944del</Attribute>
          </AttributeSet>
        </SimpleAllele>
        <TraitSet Type="Disease">
          <Trait Type="Disease">
            <XRef DB="MedGen" ID="C0037772" Type="CUI" />
          </Trait>
        </TraitSet>
        <SubmissionNameList>
          <SubmissionName>SUB12508014</SubmissionName>
          <SubmissionName>SUB14200283</SubmissionName>
        </SubmissionNameList>
      </ClinicalAssertion>
    </ClinicalAssertionList>
    <TraitMappingList>
      <TraitMapping ClinicalAssertionID="6157516" TraitType="Disease" MappingType="XRef" MappingValue="C0037772" MappingRef="MedGen">
        <MedGen CUI="C0037772" Name="Spastic paraplegia" />
      </TraitMapping>
      <TraitMapping ClinicalAssertionID="2245965" TraitType="Disease" MappingType="XRef" MappingValue="612319" MappingRef="OMIM">
        <MedGen CUI="C3496228" Name="Hereditary spastic paraplegia 35" />
      </TraitMapping>
    </TraitMappingList>
  </ClassifiedRecord>
</VariationArchive>

